• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Automated Cell Culture Equipment Market Trends

    ID: MRFR/MED/7298-CR
    115 Pages
    Kinjoll Dey
    February 2020

    Automated Cell Culture Equipment Market Research Report Information by Lab Automation Type (Modular Automation and Whole Lab Automation), by Product Type (Consumables, Equipment and Software), Application (Biopharmaceutical Production, Tissue Engineering, Vaccine Production, Gene Therapy & Regenerative Medicine, Stem Cell Therapy, Toxicity Testing and Diagnostics), End User (Pharmaceutical ...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Automated Cell Culture Equipment Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Trends

    Key Emerging Trends in the Automated Cell Culture Equipment Market

    The world is facing a significant challenge with the increasing prevalence of chronic diseases and genetic disorders. According to the Centers for Disease Control and Prevention (CDC), in 2019, about 60% of adults globally were dealing with chronic diseases, and this percentage is even higher among elderly individuals. Shockingly, it's estimated that around 70% of adults will eventually succumb to one or more chronic diseases. The situation is alarming as it poses a serious threat to public health.

    To provide some context, in the United States alone, a staggering 84.1 million people were diagnosed with prediabetes in 2019. This condition is a precursor to more severe health issues like diabetes. Furthermore, chronic lung disease affects one in every five premature babies, underscoring the vulnerability of the youngest members of our population. Breast cancer is also a prevalent concern, with one in every eight women being diagnosed with this disease.

    As individuals age, the likelihood of facing chronic diseases increases. According to CHRODIS PLUS, an initiative funded by the European Commission and other organizations, a striking eight out of ten people aged 65 and above suffer from one or more chronic diseases. These conditions include heart disease, stroke, cancer, diabetes, and Alzheimer's disease. The economic impact of chronic diseases is substantial, with European Union (EU) economies spending a massive 115 billion euros annually, equivalent to almost 0.8% of their GDP. Notably, a significant portion, ranging from 70-80%, is allocated to the treatment of chronic diseases.

    Turning our attention to genetic disorders, there are over 10,000 different types globally, caused by abnormalities in one or more genes. These disorders often run in families, meaning they can be inherited by children from their parents. The Royal Society's case study in 2017 revealed that over half a million people in the United Kingdom alone were diagnosed with a genetic disorder, emphasizing the widespread impact of these conditions. Some genetic disorders, like familial hypercholesterolemia, are more prevalent in certain regions. For instance, in the UK, around 0.4% of the population, or 1 in 250 people, are affected by familial hypercholesterolemia. Additionally, certain disorders are rarer but more common in specific ethnic groups, such as cystic fibrosis, which affects a higher number of people in Scotland compared to the global average.

    The causes of genetic disorders extend beyond gene mutations and can include environmental factors and chromosomal damage. This complexity underscores the challenges associated with addressing and preventing these conditions. While methods like DNA sequencing, gene therapy, and genome editing are emerging as potential solutions, there is a growing interest in regenerative medicine. This field holds promise for treating and mitigating the impact of both chronic diseases and genetic disorders. As the demand for regenerative medicine continues to rise, it is expected to drive market growth in the coming years, offering hope for improved health outcomes and a better quality of life for individuals facing these health challenges.

    Market Summary

    The Global Automated Cell Culture Equipment Market is projected to grow from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Automated Cell Culture Equipment Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 7.37% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 2.12 USD Billion, indicating substantial growth potential.
    • In 2024, the market is valued at 0.97 USD Billion, laying a solid foundation for future expansion.
    • Growing adoption of automated cell culture technologies due to increased demand for high-throughput screening is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.97 (USD Billion)
    2035 Market Size 2.12 (USD Billion)
    CAGR (2025-2035) 7.37%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Tecan Trading AG, Siemens, Pfizer Inc., Hitachi, Ltd, Thermo Fisher Scientific Inc., Sartorius AG, Hamilton Company, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Perkinelmer, Inc., Anton Paar GmBH, Becton, Dickinson, and Company (U.S.), HiMedia Laboratories (India), GE Healthcare (U.S.), Lonza (Switzerland), CellGenix GmbH (Germany)

    Market Trends

    The increasing demand for advanced biopharmaceuticals and regenerative medicine is driving innovation in automated cell culture technologies, which are poised to enhance research efficiency and reproducibility.

    U.S. National Institutes of Health (NIH)

    Automated Cell Culture Equipment Market Market Drivers

    Market Growth Projections

    The Global Automated Cell Culture Equipment Market Industry is projected to experience substantial growth over the coming years. The market is expected to reach approximately 0.97 USD Billion in 2024 and is forecasted to grow to around 2.12 USD Billion by 2035. This growth trajectory suggests a robust demand for automated solutions in cell culture processes. The anticipated CAGR of 7.37% from 2025 to 2035 indicates a strong market potential, driven by various factors including technological advancements, increased investment in R&D, and a rising focus on personalized medicine. This upward trend highlights the importance of automated cell culture equipment in modern biopharmaceutical development.

    Rising Demand for Biopharmaceuticals

    The Global Automated Cell Culture Equipment Market Industry experiences a notable surge in demand driven by the increasing need for biopharmaceuticals. As the global population ages and chronic diseases rise, the biopharmaceutical sector is expected to expand significantly. In 2024, the market is valued at approximately 0.97 USD Billion, reflecting the industry's growth potential. This trend is likely to continue, with projections indicating a market size of 2.12 USD Billion by 2035. The CAGR of 7.37% from 2025 to 2035 suggests that automated cell culture equipment will play a crucial role in meeting the production demands of biopharmaceuticals.

    Increased Focus on Personalized Medicine

    The Global Automated Cell Culture Equipment Market Industry is significantly influenced by the growing emphasis on personalized medicine. As healthcare shifts towards tailored therapies, the demand for advanced cell culture techniques rises. Automated cell culture systems facilitate the development of patient-specific treatments by enabling high-throughput screening and efficient cell manipulation. This trend is expected to contribute to the market's expansion, with a projected growth from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035. The CAGR of 7.37% from 2025 to 2035 indicates that automated cell culture equipment will be integral to the future of personalized medicine.

    Technological Advancements in Automation

    Technological advancements in automation are pivotal for the Global Automated Cell Culture Equipment Market Industry. Innovations such as robotics, artificial intelligence, and machine learning enhance the efficiency and precision of cell culture processes. These technologies streamline workflows, reduce human error, and improve reproducibility, which are essential for research and production. As laboratories increasingly adopt automated solutions, the market is poised for growth. The anticipated increase in market size from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035 underscores the importance of these advancements in driving the adoption of automated cell culture equipment.

    Growing Investment in Research and Development

    Investment in research and development is a critical driver for the Global Automated Cell Culture Equipment Market Industry. As organizations strive to innovate and develop new therapies, the demand for sophisticated cell culture systems increases. Enhanced funding from both public and private sectors supports the development of automated solutions that improve research outcomes. The market's growth from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035 reflects this trend. The projected CAGR of 7.37% from 2025 to 2035 indicates that sustained investment in R&D will likely propel the adoption of automated cell culture equipment.

    Regulatory Support for Advanced Cell Culture Techniques

    Regulatory bodies are increasingly supporting the adoption of advanced cell culture techniques, which positively impacts the Global Automated Cell Culture Equipment Market Industry. Guidelines that promote the use of automated systems in research and production enhance compliance and safety in biopharmaceutical manufacturing. This regulatory support encourages investment in automated technologies, leading to market growth. With the market projected to grow from 0.97 USD Billion in 2024 to 2.12 USD Billion by 2035, the role of regulatory frameworks in facilitating the adoption of automated cell culture equipment cannot be understated. The anticipated CAGR of 7.37% from 2025 to 2035 further emphasizes this trend.

    Market Segment Insights

    Regional Insights

    Key Companies in the Automated Cell Culture Equipment Market market include

    Industry Developments

    Various developments are seen in the automated cell culture equipment market which is as follows:

      • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
      • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
      • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
      • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
      • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 

    Future Outlook

    Automated Cell Culture Equipment Market Future Outlook

    The Automated Cell Culture Equipment Market is projected to grow at a 7.37% CAGR from 2024 to 2035, driven by technological advancements, increasing demand for biopharmaceuticals, and enhanced research capabilities.

    New opportunities lie in:

    • Develop automated systems for personalized medicine applications.
    • Invest in AI-driven analytics for optimized cell culture processes.
    • Expand product lines to include sustainable and eco-friendly materials.

    By 2035, the market is expected to achieve substantial growth, reflecting advancements and increased adoption across various sectors.

    Market Segmentation

    Report Overview

    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Regional Analysis

    • CellGenix GmbH (Germany).
    • Lonza (Switzerland)
    • GE Healthcare (U.S.)
    • HiMedia Laboratories (India)
    • Anton Paar GmBH . Becton, Dickinson, and Company (U.S.)
    • Perkinelmer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Beckman Coulter, Inc.
    • Hamilton Company
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Hitachi, Ltd
    • Pfizer Inc.
    • Siemens
    • Tecan Trading AG
    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Recent Development

    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Competitive Landscape

    • CellGenix GmbH (Germany).
    • Lonza (Switzerland)
    • GE Healthcare (U.S.)
    • HiMedia Laboratories (India)
    • Anton Paar GmBH . Becton, Dickinson, and Company (U.S.)
    • Perkinelmer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Beckman Coulter, Inc.
    • Hamilton Company
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Hitachi, Ltd
    • Pfizer Inc.
    • Siemens
    • Tecan Trading AG
    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Automated Cell Culture Equipment Market on end-user

    • CellGenix GmbH (Germany).
    • Lonza (Switzerland)
    • GE Healthcare (U.S.)
    • HiMedia Laboratories (India)
    • Anton Paar GmBH . Becton, Dickinson, and Company (U.S.)
    • Perkinelmer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Beckman Coulter, Inc.
    • Hamilton Company
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Hitachi, Ltd
    • Pfizer Inc.
    • Siemens
    • Tecan Trading AG
    • In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution. 
    • In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
    • In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
    • In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
    • In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
    • Recent Developments
    • Competitive Landscape
    • Regional Analysis
    • Automated Cell Culture Equipment Market Segmentation
    • Value Chain Analysis
    • Market Dynamics
    • COVID19 Analysis
    • Automated Cell Culture Equipment Market Overview

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 0.90 (USD Billion)
    Market Size 2024 0.97 (USD Billion)
    Market Size 2032 1.71 (USD Billion)
    Compound Annual Growth Rate (CAGR) 7.43 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Tecan Trading AG, Hamilton Company, Beckman Coulter, Inc., Pfizer Inc., Hitachi, Ltd, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Anton Paar GmBH, Sartorius AG, Perkinelmer, Inc., and Siemens
      Key Market Opportunities   Growing research & development (R&D) initiatives in the pharmaceutical industry
      Key Market Drivers ·  The rising prevalence of cancer and other chronic disorders demands the discovery of newer and more effective drugs for their treatment. ·  The growing incidence of cancer and other chronic diseases is anticipated to fuel the market growth

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected market value of the automated cell culture equipment market?

    Automated cell culture equipment market is touted to record a substantial market valuation of USD 1.71 Billion by 2032.

    What is the estimated growth rate of the automated cell culture equipment market?

    Automated cell culture equipment market is projected to register a moderate 7.43% CAGR in the forecast period.

    Which factors are poised to drive the automated cell culture equipment market growth?

    The massive growth of the automated cell culture equipment market is driven by the growing R&D projects in the pharmaceutical industry.

    Which type is touted to witness the highest growth?

    The modular automation segment is expected to observe substantial demand over the review period.

    Which region is expected to observe the highest growth?

    The APAC is poised to secure the highest CAGR.

    What is the application of the automated cell culture equipment market expected to witness the highest growth?

    The stem cell therapy segment is slated to mature as the fastest-growing segment.

    Who are the significant players operative in the automated cell culture equipment market?

    A few eminent market players functioning in the global automated cell culture equipment market are Siemens, Pfizer Inc., Thermo Fisher Scientific Inc., Hitachi, Ltd, among others.

    1. Executive Summary
      1. MARKET SYNOPSIS 18
    2. Market Introduction
      1. DEFINITION 19
      2. SCOPE OF THE STUDY 19
      3. RESEARCH OBJECTIVE 19
      4. MARKET STRUCTURE 20
    3. Research Methodology
      1. RESEARCH PROCESS
      2. 21
      3. PRIMARY RESEARCH 22
      4. SECONDARY RESEARCH 23
      5. MARKET SIZE
      6. ESTIMATION 23
      7. FORECAST MODEL 25
      8. LIST OF ASSUMPTIONS 26
      9. 4
    4. MARKET DYNAMICS
      1. OVERVIEW 27
      2. DRIVERS 28
        1. GROWING RESEARCH
        2. RISE IN
        3. INCREASING PREVALENCE OF CANCER
      3. AND DEVELOPMENT INITIATIVES IN THE PHARMACEUTICAL INDUSTRY 28
      4. ADOPTION OF LIQUID HANDLING SYSTEMS 28
      5. AND OTHER CHRONIC DISEASES 29
      6. RESTRAINTS 30
        1. HIGH MAINTAINANCE
      7. COST 30
      8. OPPORTUNITIES 31
        1. RISING FOCUS ON REGENERATIVE MEDICINE
      9. 31
    5. MARKET FACTOR ANALYSIS
      1. PORTER’S FIVE FORCES MODEL 32
        1. BARGAINING POWER OF SUPPLIERS 33
        2. BARGAINING POWER OF BUYERS 33
        3. THREAT OF NEW ENTRANTS 33
        4. THREAT OF SUBSTITUTES 33
      2. 5.1.5
      3. INTENSITY OF RIVALRY 33
      4. VALUE CHAIN ANALYSIS 34
        1. R&D AND
        2. MANUFACTURING 35
        3. DISTRIBUTION & SALES 35
        4. POST-SALES MONITORING 35
      5. DESIGNING 35
    6. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY LAB AUTOMATION TYPE
      2. OVERVIEW 36
      3. MODULAR AUTOMATION 38
      4. 6.3
      5. WHOLE LAB AUTOMATION 38
    7. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT
      1. TYPE
      2. OVERVIEW 39
      3. CONSUMABLES 42
      4. EQUIPMENT 42
      5. 7.4
      6. SOFTWARE 43
    8. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. 8.1
      2. OVERVIEW 44
      3. BIOPHARMACEUTICAL PRODUCTION 46
      4. TISSUE ENGINEERING
      5. 47
      6. VACCINE PRODUCTION 47
      7. DRUG SCREENING AND DEVELOPMENT 48
      8. GENE THERAPY & REGENERATIVE MEDICINE 48
      9. STEM CELL THERAPY 49
      10. TOXICITY TESTING 49
      11. DIAGNOSTICS 50
    9. GLOBAL AUTOMATED CELL CULTURE
      1. EQUIPMENT MARKET, END USER
      2. OVERVIEW 51
      3. PHARMACEUTICAL & BIOTECHNOLOGY
      4. COMPANIES 53
      5. RESEARCH AND ACADEMIC INSTITUTES 53
      6. HOSPITALS AND
      7. DIAGNOSTIC LABORATORIES 54
    10. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY REGION
      2. OVERVIEW 55
      3. AMERICAS 57
      4. AUTOMATED CELL CULTURE
    11. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      2. BY PRODUCT TYPE
    12. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    13. NORTH AMERICA 61
    14. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
      1. TYPE
    15. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED
    16. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. AUTOMATED
    17. US 64
    18. CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED CELL CULTURE
    19. EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      2. BY APPLICATION
      3. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      4. BY LAB AUTOMATION TYPE
    20. CANADA 67
    21. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT
      1. TYPE
    22. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. AMERICA 70
    23. LATIN
    24. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    25. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED CELL CULTURE
    26. EQUIPMENT MARKET, BY APPLICATION
      1. EUROPE 74
      2. AUTOMATED CELL CULTURE
    27. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      2. BY PRODUCT TYPE
    28. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    29. WESTERN EUROPE 78
    30. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB
      1. AUTOMATION TYPE
    31. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    32. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. 82
    33. GERMANY
    34. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED
    35. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT
    36. MARKET, BY APPLICATION
      1. AUTOMATED CELL CULTURE EQUIPMENT
    37. UK 85
    38. MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY
      2. PRODUCT TYPE
    39. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. 10.3.1.3
      2. FRANCE 88
    40. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
    41. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED CELL CULTURE
    42. EQUIPMENT MARKET, BY APPLICATION
      1. AUTOMATED CELL CULTURE
    43. ITALY 91
    44. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      2. BY PRODUCT TYPE
    45. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    46. SPAIN 94
    47. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
      1. TYPE
    48. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED
    49. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. 97
    50. REST OF WESTERN EUROPE
    51. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED
    52. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT
    53. MARKET, BY APPLICATION
      1. AUTOMATED CELL CULTURE
    54. EASTERN EUROPE 100
    55. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      2. BY PRODUCT TYPE
    56. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. ASIA-PACIFIC 103
    57. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
      1. TYPE
    58. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED
    59. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. AUTOMATED
    60. JAPAN 107
    61. CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED CELL CULTURE
    62. EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      2. BY APPLICATION
      3. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      4. BY LAB AUTOMATION TYPE
    63. CHINA 110
    64. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT
      1. TYPE
    65. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. 113
    66. AUSTRALIA
    67. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED
    68. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT
    69. MARKET, BY APPLICATION
      1. AUTOMATED CELL CULTURE EQUIPMENT
    70. INDIA 116
    71. MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY
      2. PRODUCT TYPE
    72. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. 10.4.5
      2. SOUTH KOREA 119
    73. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
      1. TYPE
    74. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED
    75. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    76. REST OF ASIA-PACIFIC 122
    77. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED
    78. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT
    79. MARKET, BY APPLICATION
      1. MIDDLE EAST & AFRICA 126
      2. AUTOMATED CELL
    80. CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT
    81. MARKET, BY PRODUCT TYPE
    82. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    83. MIDDLE EAST 130
    84. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
      1. TYPE
    85. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED
    86. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
      1. AUTOMATED
    87. AFRICA 133
    88. CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE
      1. AUTOMATED CELL CULTURE
    89. EQUIPMENT MARKET, BY PRODUCT TYPE
      1. AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      2. BY APPLICATION
    90. COMPETITIVE LANDSCAPE
      1. INTRODUCTION 136
      2. 11.2
      3. COMPETITIVE ANALYSIS 136
    91. COMPANY PROFILES
      1. TECAN TRADING AG 137
        1. COMPANY OVERVIEW 137
        2. FINANCIAL OVERVIEW 138
        3. PRODUCTS/SERVICES
        4. KEY DEVELOPMENTS 140
        5. SWOT ANALYSIS 141
      2. OFFERED 139
      3. 12.1.6
      4. KEY STRATEGIES 141
      5. SIEMENS 142
        1. COMPANY OVERVIEW 142
        2. PRODUCTS/SERVICES OFFERED 143
        3. KEY
        4. SWOT ANALYSIS 144
        5. KEY STRATEGIES 144
      6. 12.2.2
      7. FINANCIAL OVERVIEW 142
      8. DEVELOPMENTS 143
      9. HITACHI, LTD 145
        1. COMPANY OVERVIEW 145
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED 146
        4. KEY DEVELOPMENTS 146
        5. SWOT ANALYSIS 147
        6. KEY STRATEGIES 147
      10. 145
      11. THERMO FISHER
        1. COMPANY OVERVIEW 148
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED 149
        4. KEY DEVELOPMENTS 149
        5. SWOT ANALYSIS 150
        6. KEY STRATEGIES 150
      12. SCIENTIFIC INC. 148
      13. 148
      14. SARTORIUS AG
        1. COMPANY OVERVIEW 151
        2. FINANCIAL OVERVIEW 151
        3. KEY DEVELOPMENTS 152
        4. SWOT
        5. KEY STRATEGIES 153
      15. 151
      16. 12.5.3
      17. PRODUCTS/SERVICES OFFERED 152
      18. ANALYSIS 153
      19. HAMILTON COMPANY 154
        1. FINANCIAL OVERVIEW 154
        2. PRODUCTS/SERVICES
        3. KEY DEVELOPMENTS 154
        4. SWOT ANALYSIS 155
      20. 12.6.1
      21. COMPANY OVERVIEW 154
      22. OFFERED 154
      23. 12.6.6
      24. KEY STRATEGIES 155
      25. BECKMAN COULTER, INC. 156
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW 156
        3. PRODUCTS/SERVICES OFFERED 157
        4. KEY DEVELOPMENTS 157
        5. SWOT ANALYSIS 158
        6. KEY STRATEGIES
      26. 156
      27. 158
      28. F. HOFFMANN-LA ROCHE LTD 159
        1. COMPANY OVERVIEW 159
        2. PRODUCTS/SERVICES OFFERED 160
        3. KEY
        4. SWOT ANALYSIS 161
        5. KEY STRATEGIES 161
      29. 12.8.2
      30. FINANCIAL OVERVIEW 160
      31. DEVELOPMENTS 161
      32. PERKINELMER, INC. 162
        1. COMPANY OVERVIEW 162
        2. FINANCIAL
        3. PRODUCTS/SERVICES OFFERED 163
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS 164
        6. KEY STRATEGIES 164
      33. OVERVIEW 162
      34. 163
      35. ANTON
        1. COMPANY OVERVIEW 165
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED 165
        4. KEY DEVELOPMENTS 165
        5. SWOT ANALYSIS 166
        6. KEY STRATEGIES 166
      36. PAAR GMBH 165
      37. 165
    92. APPENDIX
      1. REFERENCES 167
      2. RELATED REPORTS 167
    93. List of Tables
      1. TABLE
    94. LIST OF ASSUMPTIONS 26
    95. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 37
    96. GLOBAL AUTOMATED
    97. CELL CULTURE EQUIPMENT MARKET FOR MODULAR AUTOMATION, BY REGION, 2020–2027
      1. (USD MILLION) 38
    98. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR
      1. WHOLE LAB AUTOMATION, BY REGION, 2020–2027
      2. (USD MILLION) 38
      3. TABLE
    99. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE, 2020–2027
      1. (USD MILLION) 40
    100. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR
      1. CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION) 40
    101. GLOBAL AUTOMATED
    102. CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE, 2020–2027 (USD MILLION)
      1. 41
    103. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY
      1. TYPE, 2020–2027 (USD MILLION) 41
    104. GLOBAL AUTOMATED CELL CULTURE
    105. EQUIPMENT MARKET FOR CONSUMABLES, BY REGION, 2020–2027 (USD MILLION) 42
    106. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR EQUIPMENT, BY REGION,
    107. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT
    108. MARKET FOR SOFTWARE, BY REGION, 2020–2027 (USD MILLION) 43
    109. GLOBAL
    110. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
      1. 46
    111. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR BIOPHARMACEUTICAL
      1. PRODUCTION, BY REGION, 2020–2027
      2. (USD MILLION) 46
    112. GLOBAL
    113. AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR TISSUE ENGINEERING, BY REGION, 2020–2027
      1. (USD MILLION) 47
    114. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR
      1. VACCINE PRODUCTION, BY REGION, 2020–2027 (USD MILLION) 47
    115. GLOBAL
    116. AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR DRUG SCREENING AND DEVELOPMENT, BY REGION,
      1. (USD MILLION) 48
    117. GLOBAL AUTOMATED CELL CULTURE
    118. EQUIPMENT MARKET FOR GENE THERAPY & REGENERATIVE MEDICINE, BY REGION,
      1. (USD MILLION) 48
    119. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR
      1. STEM CELL THERAPY, BY REGION, 2020–2027 (USD MILLION) 49
    120. GLOBAL
    121. AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR TOXICITY TESTING, BY REGION, 2020–2027
      1. (USD MILLION) 49
    122. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR
      1. DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 50
    123. GLOBAL AUTOMATED
    124. CELL CULTURE EQUIPMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 52
    125. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR PHARMACEUTICAL &
      1. BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 53
      2. TABLE
    126. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR RESEARCH AND ACADEMIC INSTITUTES,
      1. BY REGION, 2020–2027 (USD MILLION) 53
    127. GLOBAL AUTOMATED CELL
    128. CULTURE EQUIPMENT MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION,
    129. AMERICAS: AUTOMATED CELL CULTURE
    130. EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 57
    131. AMERICAS:
    132. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027
      1. (USD MILLION) 58
    133. AMERICAS: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY PRODUCT TYPE 2020–2027 (USD MILLION) 58
    134. AMERICAS: AUTOMATED
    135. CELL CULTURE EQUIPMENT MARKET FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION)
      1. 58
    136. AMERICAS: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR EQUIPMENT,
      1. BY TYPE, 2020–2027 (USD MILLION) 59
    137. AMERICAS: AUTOMATED CELL
    138. CULTURE EQUIPMENT MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION) 59
    139. AMERICAS: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027
      1. (USD MILLION) 60
    140. AMERICAS: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY END USER 2020–2027 (USD MILLION) 60
    141. NORTH AMERICA: AUTOMATED
    142. CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 61
      1. TABLE
    143. NORTH AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE,
    144. NORTH AMERICA: AUTOMATED CELL CULTURE
    145. EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 62
      1. TABLE 36
    146. NORTH AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR CONSUMABLES, BY TYPE,
    147. NORTH AMERICA: AUTOMATED CELL CULTURE
    148. EQUIPMENT MARKET FOR EQUIPMENT, BY TYPE, 2020–2027 (USD MILLION) 62
      1. TABLE
    149. NORTH AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR SOFTWARE, BY TYPE,
    150. NORTH AMERICA: AUTOMATED CELL CULTURE
    151. EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 63
      1. TABLE 40
    152. NORTH AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027
      1. (USD MILLION) 64
    153. US: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB
      1. AUTOMATION TYPE, 2020–2027 (USD MILLION) 64
    154. US: AUTOMATED CELL
    155. CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 64
      1. TABLE
    156. US: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR CONSUMABLES, BY TYPE, 2020–2027
      1. (USD MILLION) 65
    157. US: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR EQUIPMENT,
      1. BY TYPE, 2020–2027 (USD MILLION) 65
    158. US: AUTOMATED CELL CULTURE
    159. EQUIPMENT MARKET FOR SOFTWARE, BY TYPE, 2020–2027 (USD MILLION) 66
      1. TABLE
    160. US: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD
      1. MILLION) 66
    161. US: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER
    162. CANADA: AUTOMATED CELL CULTURE EQUIPMENT
    163. MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 67
    164. CANADA:
    165. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION)
      1. 67
    166. CANADA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR CONSUMABLES,
      1. BY TYPE, 2020–2027 (USD MILLION) 68
    167. CANADA: AUTOMATED CELL CULTURE
    168. EQUIPMENT MARKET FOR EQUIPMENT, BY TYPE, 2020–2027 (USD MILLION) 68
      1. TABLE
    169. CANADA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR SOFTWARE, BY TYPE, 2020–2027
      1. (USD MILLION) 69
    170. CANADA: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY APPLICATION 2020–2027 (USD MILLION) 69
    171. CANADA: AUTOMATED
    172. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 70
      1. TABLE
    173. LATIN AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE,
    174. LATIN AMERICA: AUTOMATED CELL CULTURE
    175. EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 70
      1. TABLE 57
    176. LATIN AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR CONSUMABLES, BY TYPE,
    177. LATIN AMERICA: AUTOMATED CELL CULTURE
    178. EQUIPMENT MARKET FOR EQUIPMENT, BY TYPE, 2020–2027 (USD MILLION) 71
      1. TABLE
    179. LATIN AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET FOR SOFTWARE, BY TYPE,
    180. LATIN AMERICA: AUTOMATED CELL CULTURE
    181. EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 72
      1. TABLE 61
    182. LATIN AMERICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027
      1. (USD MILLION) 73
    183. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY REGION, 2020–2027 (USD MILLION) 74
    184. EUROPE: AUTOMATED CELL
    185. CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION)
      1. 75
    186. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    187. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT
    188. MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 75
      1. TABLE 66
    189. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
      1. (USD MILLION) 76
    190. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 76
    191. EUROPE: AUTOMATED
    192. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 77
    193. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027
      1. (USD MILLION) 77
    194. WESTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT
    195. MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 78
    196. EUROPE: AUTOMATED
    197. CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION)
      1. 79
    198. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    199. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT
    200. MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 79
      1. TABLE 74
    201. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
      1. (USD MILLION) 80
    202. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 80
    203. EUROPE: AUTOMATED
    204. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 81
    205. EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027
      1. (USD MILLION) 81
    206. GERMANY: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 82
    207. GERMANY:
    208. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION)
      1. 82
    209. GERMANY: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES,
      1. BY TYPE 2020–2027 (USD MILLION) 82
    210. GERMANY: AUTOMATED CELL CULTURE
    211. EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 83
      1. TABLE
    212. GERMANY: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027
      1. (USD MILLION) 83
    213. GERMANY: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY APPLICATION 2020–2027 (USD MILLION) 84
    214. GERMANY: AUTOMATED
    215. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 84
      1. TABLE
    216. UK: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027
      1. (USD MILLION) 85
    217. UK: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT
      1. TYPE 2020–2027 (USD MILLION) 85
    218. UK: AUTOMATED CELL CULTURE EQUIPMENT
    219. MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 85
      1. TABLE 88
    220. UK: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
      1. (USD MILLION) 86
    221. UK: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR
      1. SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 86
    222. UK: AUTOMATED CELL
    223. CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 87
      1. TABLE
    224. UK: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD
      1. MILLION) 87
    225. FRANCE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB
      1. AUTOMATION TYPE, 2020–2027 (USD MILLION) 88
    226. FRANCE: AUTOMATED
    227. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 88
    228. FRANCE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY
      1. TYPE 2020–2027 (USD MILLION) 88
    229. FRANCE: AUTOMATED CELL CULTURE
    230. EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 89
      1. TABLE
    231. FRANCE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027
      1. (USD MILLION) 89
    232. FRANCE: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY APPLICATION 2020–2027 (USD MILLION) 90
    233. FRANCE: AUTOMATED
    234. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 90
      1. TABLE
    235. ITALY: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027
      1. (USD MILLION) 91
    236. ITALY: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY PRODUCT TYPE 2020–2027 (USD MILLION) 91
    237. ITALY: AUTOMATED
    238. CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION)
      1. 91
    239. ITALY: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT,
      1. BY TYPE 2020–2027 (USD MILLION) 92
    240. ITALY: AUTOMATED CELL CULTURE
    241. EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 92
      1. TABLE
    242. ITALY: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027
      1. (USD MILLION) 93
    243. ITALY: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY END USER 2020–2027 (USD MILLION) 93
    244. SPAIN: AUTOMATED CELL
    245. CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION)
      1. 94
    246. SPAIN: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE
    247. SPAIN: AUTOMATED CELL CULTURE EQUIPMENT
    248. MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 94
      1. TABLE 109
    249. SPAIN: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
      1. (USD MILLION) 95
    250. SPAIN: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 95
    251. SPAIN: AUTOMATED
    252. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 96
    253. SPAIN: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027
      1. (USD MILLION) 96
    254. REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT
    255. MARKET, BY LAB AUTOMATION TYPE, 2020–2027
      1. (USD MILLION) 97
      2. TABLE
    256. REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT
      1. TYPE 2020–2027 (USD MILLION) 97
    257. REST OF WESTERN EUROPE: AUTOMATED
    258. CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE 2020–2027
      1. (USD
      2. MILLION) 97
    259. REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT
    260. MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
      1. (USD MILLION) 98
      2. TABLE
    261. REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE,
      1. BY TYPE 2020–2027
      2. (USD MILLION) 98
    262. REST OF WESTERN EUROPE:
    263. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION)
      1. 99
    264. REST OF WESTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY END USER 2020–2027 (USD MILLION) 99
    265. EASTERN EUROPE: AUTOMATED
    266. CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION)
      1. 100
    267. EASTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT
      1. TYPE 2020–2027 (USD MILLION) 100
    268. EASTERN EUROPE: AUTOMATED
    269. CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION)
      1. 100
    270. EASTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR
      1. EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 101
    271. EASTERN EUROPE:
    272. AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD
      1. MILLION) 101
    273. EASTERN EUROPE: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY APPLICATION 2020–2027 (USD MILLION) 102
    274. EASTERN EUROPE:
    275. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION)
      1. 102
    276. ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY COUNTRY,
    277. ASIA-PACIFIC: AUTOMATED CELL CULTURE
    278. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 104
      1. TABLE
    279. ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027
      1. (USD MILLION) 104
    280. ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT
    281. MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 105
      1. TABLE 131
    282. ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
      1. (USD MILLION) 105
    283. ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT
    284. MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 106
    285. ASIA-PACIFIC:
    286. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION)
      1. 106
    287. ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END
      1. USER 2020–2027 (USD MILLION) 107
    288. JAPAN: AUTOMATED CELL CULTURE
    289. EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 107
      1. TABLE
    290. JAPAN: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027
      1. (USD MILLION) 107
    291. JAPAN: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION) 108
    292. JAPAN:
    293. AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
      1. (USD MILLION) 108
    294. JAPAN: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 109
    295. JAPAN: AUTOMATED
    296. CELL CULTURE EQUIPMENT MARKET, BY APPLICATION 2020–2027 (USD MILLION) 109
    297. JAPAN: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027
      1. (USD MILLION) 110
    298. CHINA: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY LAB AUTOMATION TYPE, 2020–2027 (USD MILLION) 110
    299. CHINA:
    300. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION)
      1. 110
    301. CHINA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES,
      1. BY TYPE 2020–2027 (USD MILLION) 111
    302. CHINA: AUTOMATED CELL CULTURE
    303. EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 111
      1. TABLE
    304. CHINA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027
      1. (USD MILLION) 112
    305. CHINA: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY APPLICATION 2020–2027 (USD MILLION) 112
    306. CHINA: AUTOMATED
    307. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 113
    308. AUSTRALIA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION
      1. TYPE, 2020–2027 (USD MILLION) 113
    309. AUSTRALIA: AUTOMATED CELL
    310. CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 113
      1. TABLE
    311. AUSTRALIA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE
    312. AUSTRALIA: AUTOMATED CELL CULTURE
    313. EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 114
      1. TABLE
    314. AUSTRALIA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027
      1. (USD MILLION) 115
    315. AUSTRALIA: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY APPLICATION 2020–2027 (USD MILLION) 115
    316. AUSTRALIA: AUTOMATED
    317. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 116
    318. INDIA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE,
    319. INDIA: AUTOMATED CELL CULTURE EQUIPMENT
    320. MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 117
    321. INDIA:
    322. AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE 2020–2027
      1. (USD MILLION) 117
    323. INDIA: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. FOR EQUIPMENT, BY TYPE 2020–2027 (USD MILLION) 117
    324. INDIA: AUTOMATED
    325. CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION)
      1. 118
    326. INDIA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    327. INDIA: AUTOMATED CELL CULTURE EQUIPMENT
    328. MARKET, BY END USER 2020–2027 (USD MILLION) 119
    329. SOUTH KOREA:
    330. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027
      1. (USD MILLION) 119
    331. SOUTH KOREA: AUTOMATED CELL CULTURE EQUIPMENT MARKET,
      1. BY PRODUCT TYPE 2020–2027 (USD MILLION) 119
    332. SOUTH KOREA: AUTOMATED
    333. CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES, BY TYPE 2020–2027 (USD MILLION)
      1. 120
    334. SOUTH KOREA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT,
      1. BY TYPE 2020–2027 (USD MILLION) 120
    335. SOUTH KOREA: AUTOMATED
    336. CELL CULTURE EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION)
      1. 121
    337. SOUTH KOREA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    338. SOUTH KOREA: AUTOMATED CELL CULTURE
    339. EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 122
    340. REST
    341. OF ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE,
      1. (USD MILLION) 122
    342. REST OF ASIA-PACIFIC: AUTOMATED
    343. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 122
    344. REST OF ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES,
      1. BY TYPE 2020–2027
      2. (USD MILLION) 123
    345. REST OF ASIA-PACIFIC:
    346. AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
      1. (USD MILLION) 123
    347. REST OF ASIA-PACIFIC: AUTOMATED CELL CULTURE
    348. EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027 (USD MILLION) 124
      1. TABLE
    349. REST OF ASIA-PACIFIC: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY APPLICATION
    350. REST OF ASIA-PACIFIC: AUTOMATED
    351. CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION) 125
    352. MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY
      1. REGION, 2020–2027 (USD MILLION) 126
    353. MIDDLE EAST & AFRICA:
    354. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB AUTOMATION TYPE, 2020–2027
      1. (USD MILLION) 127
    355. MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE
    356. EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 127
      1. TABLE 180
      2. MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES,
      3. BY TYPE 2020–2027
      4. (USD MILLION) 127
    357. MIDDLE EAST &
    358. AFRICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027
      1. (USD MILLION) 128
    359. MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE
    360. EQUIPMENT MARKET, FOR SOFTWARE, BY TYPE 2020–2027
      1. (USD MILLION) 128
    361. MIDDLE EAST & AFRICA: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY
      1. APPLICATION 2020–2027 (USD MILLION) 129
    362. MIDDLE EAST & AFRICA:
    363. AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY END USER 2020–2027 (USD MILLION)
      1. 129
    364. MIDDLE EAST: AUTOMATED CELL CULTURE EQUIPMENT MARKET, BY LAB
      1. AUTOMATION TYPE, 2020–2027 (USD MILLION) 130
    365. MIDDLE EAST: AUTOMATED
    366. CELL CULTURE EQUIPMENT MARKET, BY PRODUCT TYPE 2020–2027 (USD MILLION) 130
    367. MIDDLE EAST: AUTOMATED CELL CULTURE EQUIPMENT MARKET, FOR CONSUMABLES,
      1. BY TYPE 2020–2027 (USD MILLION) 130
    368. MIDDLE EAST: AUTOMATED
    369. CELL CULTURE EQUIPMENT MARKET, FOR EQUIPMENT, BY TYPE 2020–2027 (U

    Automated Cell Culture Equipment Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027